SCHULER JACK W purchased $1.0M of BDSX (indirect holdings)
SCHULER JACK W purchased 100,000 indirectly-held shares of BIODESIX INC (BDSX) at $10.02 ($1.00M total) on 2026-11-10.
How this was made
The 30-second read
Why it matters
The $1M purchase modestly raises the insider's ownership, but the amount is small relative to market cap, limiting price impact.
Market read
The filing provides a fresh data point for traders monitoring insider activity, but its modest size limits actionable trading decisions.
What to watch
Potential upcoming clinical data or partnership announcements could amplify the relevance of the insider trade.
Background
Form 4 filings disclose insider transactions; investors watch them for signals of confidence or concern.
Ticker impact
SEC Form 4 shows insider Jack S. Schuler bought 100,000 shares for $1.0M, increasing his stake to 655,810 shares.
likely slight upward pressure as market prices in insider confidence
The purchase size is modest for a micro‑cap, but insider buying often nudges sentiment positively.
Market effects
Minimal; biotech sector not materially affected by a single insider trade.
None; the filing is company‑specific.
Low; no broader market impact.
Counterpoint
The purchase could be routine portfolio rebalancing, not a strong bullish signal.
Key entities
- InsiderJack W. Schuler
10% owner of Biodesix who made the disclosed purchase.
- CompanyBiodesix Inc.
US‑listed biotech (ticker BDSX) focused on diagnostic testing.
